Skip to main content
Log in

Progression from paroxysmal to persistent atrial fibrillation in pacemaker patients with tachycardia–bradycardia syndrome: a multicenter study

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Progression from paroxysmal to persistent atrial fibrillation (AF) is occasionally encountered in patients with previous pacemaker implantation (PMI) for the treatment of tachycardia–bradycardia syndrome (TBS). We aimed to determine the rate of its incidence occurring within the early years after PMI and the predictors. We studied TBS patients who received PMI at 5 core cardiovascular centers. The end point was a conversion from paroxysmal to persistent AF. We extracted 342 TBS patients out of 2579 undergoing PMI. During 5 ± 3.1 years of follow-up, 114 (33.3%) reached the end point. The time to the end point was 2.9 ± 2.7 years. The event rates within a year and 3 years after the PMI were 8.8% and 19.6%, respectively. In the multivariate hazard analyses, hypertension (hazard ratio [HR] 3.2, P = 0.03) and congestive heart failure (HR 2.1, P = 0.04) were found to be independent predictors of the end point occurring within a year after the PMI. Congestive heart failure (HR 1.82, P = 0.04), left atrial diameter of ≥ 40 mm (HR 4.55, P < 0.001), and the use of antiarrhythmic agents (HR 0.58, P = 0.04) were independently associated with the 3-year end point. Prediction models including combinations of those 4 parameters for the 1- and 3-year incidence both exhibited a modest risk discrimination (both c-statistics 0.71). In conclusion, early progression from paroxysmal to persistent AF was less frequent than expected in the TBS patients with PMI. Factors related to atrial remodeling and no use of antiarrhythmic drugs may facilitate the progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. John RM, Kumar S (2016) Sinus node and atrial arrhythmias. Circulation 133:1892–1900

    Article  PubMed  Google Scholar 

  2. Jackson LR 2nd, Rathakrishnan B, Campbell K, Thomas KL, Piccini JP, Bahnson T, Stiber JA, Daubert JP (2017) Sinus node dysfunction and atrial fibrillation: a reversible phenomenon? Pacing Clin Electrophysiol 40:442–450

    Article  PubMed  Google Scholar 

  3. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 14:e275–e444

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kaplan BM, Langendorf R, Lev M, Pick A (1973) Tachycardia–bradycardia syndrome (so-called “sick sinus syndrome”). Pathology, mechanisms and treatment. Am J Cardiol 31:497–508

    Article  CAS  PubMed  Google Scholar 

  5. Padfield GJ, Steinberg C, Swampillai J, Qian H, Connolly SJ, Dorian P, Green MS, Humphries KH, Klein GJ, Sheldon R, Talajic M, Kerr CR (2017) Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. Heart Rhythm 14:801–807

    Article  PubMed  Google Scholar 

  6. Boriani G, Tukkie R, Manolis AS, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, de Sousa J, Botto GL, Mangoni L, Grammatico A, Padeletti L, Investigators MINERVA (2014) Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J 35:2352–2362

    Article  PubMed  PubMed Central  Google Scholar 

  7. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ (2010) Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55:725–731

    Article  PubMed  Google Scholar 

  8. Shibata N, Kondo T, Morimoto R, Kazama S, Sawamura A, Nishiyama I, Kato T, Kuwayama T, Hiraiwa H, Umemoto N, Asai T, Okumura T, Murohara T (2022) Clinical value of the HATCH score for predicting adverse outcomes in patients with heart failure. Heart Vessels 37:1363–1372

    Article  PubMed  Google Scholar 

  9. Akoum N, McGann C, Vergara G, Badger T, Ranjan R, Mahnkopf C, Kholmovski E, Macleod R, Marrouche N (2012) Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol 23:44–50

    Article  PubMed  Google Scholar 

  10. Kochhäuser S, Dechering DG, Trought K, Hache P, Haig-Carter T, Khaykin Y, Wulffhart Z, Pantano A, Tsang B, Eckardt L, Verma A (2016) Predictors for progression of atrial fibrillation in patients awaiting atrial fibrillation ablation. Can J Cardiol 32:1348–1354

    Article  PubMed  Google Scholar 

  11. Ukita K, Egami Y, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, Okamoto N, Matsunaga-Lee Y, Yano M, Nishino M, Tanouchi J (2022) Impact of radiofrequency catheter ablation for atrial fibrillation in patients with left atrial enlargement. Heart Vessels 37:1899–1905

    Article  PubMed  Google Scholar 

  12. Saksena S, Hettrick DA, Koehler JL, Grammatico A, Padeletti L (2007) Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. Am Heart J 154:884–892

    Article  PubMed  Google Scholar 

  13. Hocini M, Sanders P, Deisenhofer I, Jaïs P, Hsu LF, Scavée C, Weerasoriya R, Raybaud F, Macle L, Shah DC, Garrigue S, Le Metayer P, Clémenty J, Haïssaguerre M (2003) Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation 108:1172–1175

    Article  PubMed  Google Scholar 

  14. Chung H, Uhm JS, Sung JH, Kim JY, Pak HN, Lee MH, Joung B (2014) The type of sinus node dysfunction might predict the severity of atrial remodeling and clinical outcome after catheter ablation of atrial fibrillation. Int J Cardiol 172:487–489

    Article  PubMed  Google Scholar 

  15. Shimizu A, Centurion OA (2002) Electrophysiological properties of the human atrium in atrial fibrillation. Cardiovasc Res 54:302–314

    Article  CAS  PubMed  Google Scholar 

  16. Sugihara C, Veasey R, Freemantle N, Podd S, Furniss S, Sulke N (2015) The development of AF over time in patients with permanent pacemakers: objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF. Europace 17:864–870

    Article  PubMed  Google Scholar 

Download references

Funding

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akinori Sairaku.

Ethics declarations

Conflict of interest

None declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oguri, N., Sairaku, A., Morishima, N. et al. Progression from paroxysmal to persistent atrial fibrillation in pacemaker patients with tachycardia–bradycardia syndrome: a multicenter study. Heart Vessels 38, 1149–1155 (2023). https://doi.org/10.1007/s00380-023-02266-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-023-02266-5

Keywords

Navigation